FEATURED/ARCHIVES (29/04/24)
×
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study · April 2021
Articles
Schizophrenia Bulletin Open
×
Characteristics Associated with the Risk of Psychosis among Immigrants and Their Descendants in France · April 2021
Articles
Brain and Behavior
×
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia · October 2021
Articles
CNS Drugs
×
Jumping to Conclusions, General Intelligence, and Psychosis Liability: Findings from the Multi-Centre EU-GEI Case-Control Study · April 2020
Articles
Psychological Medicine
×
Impact of Preexisting Alcohol Use Disorder, Bipolar Disorder, and Schizophrenia on Ischemic Stroke Risk and Severity: A Lebanese Case-Control Study · February 2023
Articles
Healthcare
×
Can Computational Models Help Elucidate the Link between Complex Trauma and Hallucinations? · June 2023
Articles
Schizophrenia Research
×
Antipsychotics and Risk of QT Prolongation: A Pharmacovigilance Study · December 2022
Abstracts
Psychopharmacology
×
Cognitive Performance at First Episode of Psychosis and the Relationship with Future Treatment Resistance: Evidence from an International Prospective Cohort Study · March 2023
Articles
Schizophrenia Research
×
Predictors of Internalized Stigma in Patients with Schizophrenia in Northern Chile: A Longitudinal Study · November 2022
Articles
Healthcare
×
Effectiveness of a Therapeutic Educational Oral Health Program for Persons with Schizophrenia: A Cluster Randomized Controlled Trial and Qualitative Approach · July 2023
Articles
Healthcare
×
Symptomatic and Functional Outcomes After Treatment with Paliperidone Palmitate 3-Month Formulation for 52 Weeks in Patients with Clinically Stable Schizophrenia · May 2020
Articles
Therapeutic Advances in Psychopharmacology
×
Long-Term Effects of Roluperidone on Negative Symptoms of Schizophrenia · March 2023
Articles
Schizophrenia Research
×
New Insights into Quetiapine Metabolism Using Molecular Networking · November 2020
Articles
Scientific Reports
×
Clinical Predictors of Antipsychotic Treatment Resistance: Development and Internal Validation of a Prognostic Prediction Model by the STRATA-G Consortium · October 2022
Articles
Schizophrenia Research
×
Real-World Effectiveness of Long-Acting Injectable Antipsychotic Treatments in a Nationwide Cohort of 12,373 Patients with Schizophrenia-Spectrum Disorders · July 2023
Articles
Molecular Psychiatry
×
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis · October 2021
Articles
Patient Preference and Adherence
×
Electroencephalography Microstates Imbalance Across the Spectrum of Early Psychosis, Autism, and Mood Disorders · May 2023
Articles
European Psychiatry
×
Baseline Levels of C-Reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: The OPTiMiSE Cohort Study · May 2021
Articles
Schizophrenia Bulletin Open